To verify our findings on the role of TGF-β on OPN splicing, we selected SK-MES-1 cells, a different type of NSCLC cell of squamous cell origin, and treated with TGF-β (5 ng/ml) for 48 h. Here, SPP1 is linked to non-small cell lung carcinoma.